Live Breaking News & Updates on பொறியியலாளர் ஆதரவு கட்டமைப்புகள்

Stay updated with breaking news from பொறியியலாளர் ஆதரவு கட்டமைப்புகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scientists Engineer New 'Living Materials' by Hacking The Basis of Kombucha


Scientists Engineer New Living Materials by Hacking The Basis of Kombucha
12 JANUARY 2021
Scientists have created new kinds of living materials by tweaking the base ingredients of kombucha – the popular tea drink fermented with a symbiotic culture of bacteria and yeast (aka SCOBY).
 
This kind of tea fungus – sometimes called kombucha mother – can do a lot more than just produce sour-tasting beverages, it seems.
By modifying the mixture of the culture, researchers were able to make engineered living materials (ELMs) that could one day have all sorts of practical applications, such as sensing light or detecting contaminants.
Better still, the scientists say these living materials can easily be made at home, much like tending a sourdough starter in your kitchen. ....

City Of , United Kingdom , Charlie Gilbert , Tzu Chieh Tang , Imperial College London , Imperial College , Rachel Smith , Amp Quot , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , சார்லி கில்பர்ட் , ட்ஸூ சிஎ டாங் , ஏகாதிபத்தியம் கல்லூரி லண்டன் , ஏகாதிபத்தியம் கல்லூரி , ரேச்சல் ஸ்மித் ,

Carbalive: The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis


(2)
The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis
Patients treated with orally-administered, non-absorbable engineered carbon of controlled porosity was safe, tolerable and showed trends in improvements in a range of biomarkers of systemic inflammation
The mechanism of this effect is modulation of dysbiosis, gut inflammation and leaky gut that are characteristic of cirrhosis
Planning for pivotal trials to support approval in Europe is now under way
7
th January, 2021 - The
CARBALIVE Consortium( CARBALIVE or the Consortium ) is pleased to announce positive data from the Phase 2 equivalent randomised, double-blind clinical trial of Carbalive, a product candidate for the treatment of patients with decompensated cirrhosis. Carbalive is specifically designed to remove harmful bacterial toxins from the gut, reduce gut inflammation and its permeabilit ....

Rajiv Jalan , Amber Fennell , Universitario Ram , Agustin Albillos , Akaza Bioscience , Zenios Bioscience , Jane Macnaughtan , Kostenloser Wertpapierhandel , University College London , European Union Horizon , Liver Failure Group At University College London , Cajal Institute For Health , Digestive Diseases Group , Carbalive Consortium , Consilium Strategic Communications , European Foundation , Chronic Liver Failure , European Union , Professor Rajiv Jalan , Liver Failure Group , Founding Member , Project Coordinator , Hospital Universitario Ram , Universidad De Alcal , Cajal Institute , Takeda Pharmaceutical ,